European Archives - Page 104 of 1111 - European Medical Journal

Alzheimer’s Breakthrough: Lecanemab and its Role in Reducing Neurodegeneration

Lecanemab targets toxic amyloid-β protofibrils in Alzheimer’s disease, correlating with reduced neurodegeneration and cognitive decline.

Bronchiectasis and Inflammation – Epidemiology, Diagnosis and Treatment in a Nutshell

Bronchiectasis is a multifaceted condition with unique diagnostic and treatment considerations, presenting significant challenges for…

Brain Age Linked to Cognitive Impairment in Sickle Cell Anaemia and Economic Deprivation

A recent study shows brain age modelling can help understand cognitive impairments in adults with sickle cell anemia and economic deprivation.

Glucose Monitors Able to Predict Diabetes Complications

Continuous glucose monitors have been found to predict complications in patients with Type 1 diabetes.

Innovative Immunotherapy Shows Promise in Preventing Skin Cancer

By leveraging the immune-activating properties of epithelial cells, this study highlights the transformative potential of Th2 immunity in early cancer intervention.

How Do Gut Microbes Shape Immunity? Interview with Dennis Lee Kasper

It takes an interdisciplinary approach to solve complex problems in the microbiome because you couldn’t ask for a more complex system.

Early Intervention in MS

A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…

EMJ Neurology 13 [Supplement 2] 2025

A satellite symposium titled ‘Transforming MS Care: Early Intervention and Sustained Safety’ held at the 40th Congress of the European…

Alcohol's Role in Progression of HBV-Related Liver Disease

Alcohol consumption exacerbates the risk of cirrhosis and hepatocellular carcinoma, promoting hepatitis B virus replication and weakening immunity.

The 2025 pharma forecast

Curious to know could happen in the industry in 2025? Join us as we talk to three guests about their top predictions for the year ahead.